XML 20 R8.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net income $ 16,698 $ 28,515
Adjustments to reconcile net income to cash flow from operating activities:    
Depreciation and amortization 118,521 107,850
Accretion of loan discounts and premiums, net (4,014) (4,679)
Amortization of deferred financing costs, net 1,809 1,379
Stock compensation expense 5,797 5,250
(Gain on sale) loss on impairment of real estate assets, net (1,496) (10,378)
Loss (gain) on extinguishment of debt 67 (203)
Amortization related to derivative instruments 506 614
Non-cash casualty losses 400 1,510
Equity in loss from investments in unconsolidated real estate entities 1,151 1,679
Other non-cash loss 103 1
Changes in assets and liabilities:    
Other assets 3,077 5,145
Accounts payable and accrued expenses 1,379 (7,827)
Accrued interest payable (815) (1,122)
Other liabilities (569) (654)
Cash flow provided by operating activities 142,614 127,080
Cash flows from investing activities:    
Acquisition of real estate properties (58,637) 0
Escrow deposits for pending real estate acquisitions (3,818) 0
Investments in unconsolidated real estate entities (16,096) (2,982)
Proceeds from dispositions of real estate properties, net 109,203 320,606
Capital expenditures (53,677) (55,698)
Real estate development expenditures (12,242) (26,884)
Proceeds from insurance claims 925 3,511
Cash flow (used in) provided by investing activities (34,342) 238,553
Cash flows from financing activities:    
Proceeds (costs) from issuance of common stock, net 49,883 (72)
Proceeds from unsecured revolver 243,414 131,000
Unsecured revolver and secured credit facility repayments (223,000) (262,652)
Mortgage principal repayments and payoffs (94,423) (159,675)
Payment for deferred financing costs (5,636) (357)
Distributions on common stock (74,113) (72,104)
Distributions to noncontrolling interests (1,902) (1,901)
Payment for debt extinguishment (1) (663)
Repurchase of shares related to equity award tax withholding (3,420) (2,543)
Cash flow used in financing activities (109,198) (368,967)
Net change in cash and cash equivalents, and restricted cash (926) (3,334)
Cash and cash equivalents, and restricted cash, beginning of period 43,452 50,732
Cash and cash equivalents, and restricted cash, end of the period 42,526 47,398
Reconciliation of cash, cash equivalents, and restricted cash to the Condensed Consolidated Balance Sheets    
Cash and cash equivalents 19,491 21,034
Restricted Cash 23,035 26,364
Total cash, cash equivalents, and restricted cash, end of period $ 42,526 $ 47,398